APA (7th ed.) Citation

Reynolds, W. F., Sermet-Gaudelus, I., Gausson, V., Feuillet, M., Bonnefont, J., Lenoir, G., . . . Witko-Sarsat, V. Myeloperoxidase Promoter Polymorphism −463G Is Associated With More Severe Clinical Expression of Cystic Fibrosis Pulmonary Disease. Wiley.

Chicago Style (17th ed.) Citation

Reynolds, Wanda F., Isabelle Sermet-Gaudelus, Valérie Gausson, Marie-Noëlle Feuillet, Jean-Paul Bonnefont, Gérard Lenoir, Béatrice Descamps-Latscha, and Véronique Witko-Sarsat. Myeloperoxidase Promoter Polymorphism −463G Is Associated With More Severe Clinical Expression of Cystic Fibrosis Pulmonary Disease. Wiley.

MLA (9th ed.) Citation

Reynolds, Wanda F., et al. Myeloperoxidase Promoter Polymorphism −463G Is Associated With More Severe Clinical Expression of Cystic Fibrosis Pulmonary Disease. Wiley.